Atorvastatin News and Research

RSS
Cholesterol drugs clash head on

Cholesterol drugs clash head on

Atherosclerotic plaques spread downstream in coronary arteries

Atherosclerotic plaques spread downstream in coronary arteries

Rosuvastatin as effective as atorvastatin in reversing atherosclerosis

Rosuvastatin as effective as atorvastatin in reversing atherosclerosis

Watson third quarter net income increases 31% to $138.7 million

Watson third quarter net income increases 31% to $138.7 million

Statins protect people against death from respiratory illness, infections

Statins protect people against death from respiratory illness, infections

Shear stress-based method can identify vulnerable plaque in coronary arteries

Shear stress-based method can identify vulnerable plaque in coronary arteries

High dose statins raise risk of diabetes: Study

High dose statins raise risk of diabetes: Study

Cholesterol-lowering statins reduce rate of mortality and cardiovascular events

Cholesterol-lowering statins reduce rate of mortality and cardiovascular events

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Top-line results from Amarin's AMR101 Phase 3 trial in patients with high triglycerides

Top-line results from Amarin's AMR101 Phase 3 trial in patients with high triglycerides

Statin drug may help prevent blindness in diabetics

Statin drug may help prevent blindness in diabetics

Clinical trial finds atorvastatin may inhibit HIV progression, help in infection's management

Clinical trial finds atorvastatin may inhibit HIV progression, help in infection's management

Mylan enters settlement agreement with Pfizer for Caduet Tablets litigation

Mylan enters settlement agreement with Pfizer for Caduet Tablets litigation

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

FDA approves Novartis' Amturnide for treatment of high blood pressure

FDA approves Novartis' Amturnide for treatment of high blood pressure

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Statin drugs do not benefit pediatric lupus patients

Statin drugs do not benefit pediatric lupus patients

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases